Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
49m
Ideaya Biosciences Advances Synthetic Lethality With IDE397 Success
IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.
gaycitynews
50m
Injectable PrEP continues to show promising results
There are now multiple forms of injectable PrEP medications. Lenacapavir, which is Gilead's injectable drug, differs from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Disney to stop using Slack
Secret Service probing post
$230 million crypto theft
FCC chair denies Trump call
Body found in SUV
Cancels appearance w/ Duda
Boy kills bear, saves father
Stein's ballot bid rejected
Ban called for in TX schools
MS sheriff's office probe
Recalling 449K+ vehicles
'Targeted strike' in Beirut
$3B for battery projects
To visit US next week
Brazil threatens daily fines
Collapse hazard recall
Vows to remain in race
160M euros to Ukraine
To get a second moon
Families lose appeal
FTC on privacy controls
Raises settlement offer
Man charged for threats
PGA welcomes LIV players
NYC subway joyride arrest
Hold campaign event in MI
COVID, Wuhan market link
Overdose deaths drop in US
Makes MLB history
Related topics
HIV
S&P 500 Index
lenacapavir
Yuhan
Feedback